Recent news on Lepirudin

New deals for ProBioGens cell engineering group  -  Apr 25, 2007
In-PharmaTechnologist.com,The product is a biosimilar version of Bayer's Refludan (lepirudin). It also sells biosimilar versions of interferon alfa-2a and pegylated interferon

CEO: Pharmion Has Evolved, Could 'Transform' During '07  -  Jan 10, 2007
BioWorld Online,It markets Innohep (tinzaparin), a low-molecular-weight heparin approved in the US for deep-vein thrombosis, as well as Refludan (lepirudin),

Celsus to Commence Phase I Clinical Studies of Intimatan  -  Jan 2, 2007
PharmaLive.com (press release),There are no antidotes for low molecular weight heparin and the direct thrombin inhibitors, hirudin, lepirudin, bivalirudin and argatroban.

Revised Refludan Prescribing Information  -  Nov 15, 2006
Facts and Comparisons,The FDA has revised the prescribing information for Refludan (lepirudin) to include information for use in patients scheduled for transition to oral

Pharmion Acquires Cabrellis: $59M For Lung Cancer Drug  -  Nov 16, 2006
BioWorld Online,It also markets Innohep (tinzaparin), a low-molecular-weight heparin approved in the US for deep-vein thrombosis, and Refludan (lepirudin), an antithrombin



New anticoagulants are under development  Apr 20, 2006
Two parenteral direct thrombin inhibitors, lepirudin and argatroban, have FDA approval for the management of heparin-induced thrombocytopenia.". ... - Therapeutics Daily (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional